Sunbelt Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Sunbelt Securities's ARKG Position: Q1 2026 in Review
Sunbelt Securities reduced its ARK Genomic Revolution ETF (ARKG) stake by 72% in Q1 2026, selling an estimated $2.84K and leaving 37 shares worth $978. The position accounts for ﹤0.01% of the portfolio, ranked #2103.
Sunbelt Securities first reported a position in ARKG in Q1 2021 and has held it in 14 quarters since. The position peaked at $225K in Q1 2021. 219 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Sunbelt Securities held 37 shares of ARK Genomic Revolution ETF worth $978 as of Q1 2026.
- Sunbelt Securities sold 97 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $2.84K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2103 holding.
- Sunbelt Securities first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 14 quarters since.
- Sunbelt Securities's ARK Genomic Revolution ETF position peaked at $225K in Q1 2021.
- 219 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.